Literature DB >> 7082544

6 beta-hydroxycortisol excretion in relation to polymorphic N-oxidation of sparteine.

B K Park, M Eichelbaum, E E Ohnhaus.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7082544      PMCID： PMC1402067          DOI： 10.1111/j.1365-2125.1982.tb01448.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  14 in total

1.  Measurement of urinary 6-beta-hydroxycortisol excretion as an in vivo parameter in the clinical assessment of the microsomal enzyme-inducing capacity of antipyrine, phenobarbitone and rifampicin.

Authors:  E E Ohnhaus; B K Park
Journal:  Eur J Clin Pharmacol       Date:  1979-03-26       Impact factor: 2.953

2.  Urinary 17-hydroxycorticosteroid determination with p-hydrazinobenzenesulfonic acid-phosphoric acid.

Authors:  A Sanghvi; C Wight; B Parikh; H Desai
Journal:  Am J Clin Pathol       Date:  1973-11       Impact factor: 2.493

3.  [Polymorphisms and deficient drug metabolism as triggers of toxic reactions (author's transl)].

Authors:  H J Dengler; M Eichelbaum
Journal:  Arzneimittelforschung       Date:  1977

4.  Pharmacogenetic covariation of defective N-oxidation of sparteine and 4-hydroxylation of debrisoquine.

Authors:  L Bertilsson; H J Dengler; M Eichelbaum; H U Schulz
Journal:  Eur J Clin Pharmacol       Date:  1980-02       Impact factor: 2.953

5.  Nortriptyline and antipyrine clearance in relation to debrisoquine hydroxylation in man.

Authors:  L Bertilsson; M Eichelbaum; B Mellström; J Säwe; H U Schulz; F Sjöqvist
Journal:  Life Sci       Date:  1980-11-03       Impact factor: 5.037

6.  A direct radioimmunoassay for 6 beta-hydroxycortisol in human urine.

Authors:  B K Park
Journal:  J Steroid Biochem       Date:  1978-10       Impact factor: 4.292

7.  Defective N-oxidation of sparteine in man: a new pharmacogenetic defect.

Authors:  M Eichelbaum; N Spannbrucker; B Steincke; H J Dengler
Journal:  Eur J Clin Pharmacol       Date:  1979-09       Impact factor: 2.953

8.  The effects of phenobarbitone on urinary 6 beta-hydroxycortisol excretion and hepatic enzyme activity in the marmoset monkey (Callithrix jacchus).

Authors:  M R Challiner; B K Park; J Odum; T C Orton; G L Parker
Journal:  Biochem Pharmacol       Date:  1980-12       Impact factor: 5.858

9.  Deficient metabolism of debrisoquine and sparteine.

Authors:  T Inaba; S V Otton; W Kalow
Journal:  Clin Pharmacol Ther       Date:  1980-04       Impact factor: 6.875

10.  Polymorphic hydroxylation of Debrisoquine in man.

Authors:  A Mahgoub; J R Idle; L G Dring; R Lancaster; R L Smith
Journal:  Lancet       Date:  1977-09-17       Impact factor: 79.321
View more
  7 in total

Review 1.  Addressing phenoconversion: the Achilles' heel of personalized medicine.

Authors:  Rashmi R Shah; Robert L Smith
Journal:  Br J Clin Pharmacol       Date:  2015-02       Impact factor: 4.335

2.  The influence of enzyme induction on polymorphic sparteine oxidation.

Authors:  M Eichelbaum; S Mineshita; E E Ohnhaus; C Zekorn
Journal:  Br J Clin Pharmacol       Date:  1986-07       Impact factor: 4.335

Review 3.  Assessment of the drug metabolism capacity of the liver.

Authors:  B K Park
Journal:  Br J Clin Pharmacol       Date:  1982-11       Impact factor: 4.335

4.  The increase in urinary excretion of 6 beta-hydroxycortisol as a marker of human hepatic cytochrome P450IIIA induction.

Authors:  C Ged; J M Rouillon; L Pichard; J Combalbert; N Bressot; P Bories; H Michel; P Beaune; P Maurel
Journal:  Br J Clin Pharmacol       Date:  1989-10       Impact factor: 4.335

5.  Urinary bile acid and bile alcohol excretion does not reflect the genetic polymorphism of debrisoquine hydroxylation.

Authors:  G Karlaganis; A Küpfer; R Preisig
Journal:  Br J Clin Pharmacol       Date:  1984-04       Impact factor: 4.335

6.  2-Hydroxylation of ethinyloestradiol in relation to the oxidation of sparteine and antipyrine.

Authors:  D J Back; J L Maggs; H S Purba; S Newby; B K Park
Journal:  Br J Clin Pharmacol       Date:  1984-10       Impact factor: 4.335

Review 7.  Urinary 6beta-hydroxycortisol: a validated test for evaluating drug induction or drug inhibition mediated through CYP3A in humans and in animals.

Authors:  M M Galteau; F Shamsa
Journal:  Eur J Clin Pharmacol       Date:  2003-11-06       Impact factor: 2.953
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.